FHA
CMD

Flagship Harbor Advisors’s Cantel Medical Corporation CMD Stock Holding History

Flagship Harbor Advisors’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-192
Closed -$14K – 2028
2019
Q4 		$14K Hold
192
– – ﹤0.01% 1247
2019
Q3 		$14K Hold
192
– – ﹤0.01% 1211
2019
Q2 		$15K Sell
192
-875
-82% -$61.5K ﹤0.01% 1174
2019
Q1 		$71K Buy
+1,067
New +$80.8K 0.01% 660
2018
Q4 		– Sell
-104
Closed -$10K – 2175
2018
Q3 		$10K Hold
104
– – ﹤0.01% 1443
2018
Q2 		$10K Buy
+104
New +$11.6K ﹤0.01% 1398

Other funds holding CMD

BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return
DM
Diker Management New York $130M AUM 97.77% 1-Year Est. Return

Flagship Harbor Advisors's CMD Position: Q1 2020 in Review

Flagship Harbor Advisors sold out of Cantel Medical Corporation (CMD) in Q1 2020, closing a stake of 192 shares — an estimated $14K sold.

Flagship Harbor Advisors first reported a position in CMD in Q2 2018 and held it in 6 quarters. The position peaked at $71K in Q1 2019. 213 funds tracked by Wall St. Rank hold CMD as of Q1 2020.

  • Flagship Harbor Advisors reported no remaining Cantel Medical Corporation position as of Q1 2020 after selling out during the quarter.
  • Flagship Harbor Advisors sold 192 Cantel Medical Corporation shares in Q1 2020, an estimated $14K.
  • Flagship Harbor Advisors first reported a position in Cantel Medical Corporation in Q2 2018 and held it in 6 quarters.
  • Flagship Harbor Advisors's Cantel Medical Corporation position peaked at $71K in Q1 2019.
  • 213 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q1 2020.

Based on Flagship Harbor Advisors's 13F filing for Q1 2020, filed 12 May 2020.